News and Trends 26 Dec 2025 When biotech makes Christmas miracles happen — second edition As 2025 comes to a close, delve into some biotech feel-good stories where the right treatment meets the right patient, almost feeling like a miracle. December 26, 2025 - 7 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 19 Dec 2025 U.S. vaccine approvals to undergo overhaul: what do the changes mean? A strict new vaccine approval process in the U.S. could dramatically slow things down for biopharma and the public, experts warn. December 19, 2025 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 8 Dec 2025 Top biotech deals in November 2025 An end-of-the-year slowdown has not been witnessed by the biopharma industry yet, and certainly not in the biotech deals space in November. December 8, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 2 Dec 2025 Vandria reports VNA-318’s first-in-human data in Alzheimer’s Delve into Vandria’s technology and its Alzheimer’s candidate, VNA-318, the first mitophagy-based candidate in Alzheimer’s to reach the clinic. December 2, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 13 Nov 2025 iGEM Jamboree: leap into the synthetic biology future From plastic-eating plants to AI-guided therapies, iGEM 2025 reveals the innovations defining the future of synthetic biology. November 13, 2025 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 12 Nov 2025 New cancer cell discovery sheds light on childhood blood cancer The discovery of new cancer cells with a switched-on gene called ZBTB16 is a breakthrough in childhood blood cancer research. November 12, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 10 Nov 2025 BIO-Europe partnering: Australian biotech companies share their experiences Australian biotechs share lessons from BIO-Europe on building global partnerships and driving growth beyond their domestic market. November 10, 2025 - 9 minutesmins - By Dylan Kissane Share WhatsApp Twitter Linkedin Email
News and Trends 3 Nov 2025 AAVantgarde closes $141 million series B round to tackle inherited eye diseases Today AAvantgarde closes a $141 million series B round to advance its inherited eye diseases pipeline; find out more about its approach! November 3, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 24 Oct 2025 The ESMO 2025 digest: Is oncology in good shape? The 2025 edition of the European Society for Medical Oncology (ESMO) was held this week in Berlin, delve into its key highlights. October 24, 2025 - 6 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 22 Oct 2025 Deal after deal: Novartis spends billions in 2025 Novartis has been on a shopping spree of late. Find out about the pharma giant’s latest deals of 2025. October 22, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 10 Oct 2025 Practical partnering at BIOSPAIN: on the ground with biotech innovators ready to take the next step We were on the ground in Barcelona speaking to biotech companies, university technology transfer offices, and top pharma firms about their experience at BIOSPAIN and their progress towards securing partnerships. October 10, 2025 - 8 minutesmins - By Dylan Kissane Share WhatsApp Twitter Linkedin Email
News and Trends 9 Oct 2025 Are European biotech VCs under pressure to scale? Time to get pragmatic As Asabys Partners has rolled Aliath Bioventures into its platform, it’s worth asking if European biotech VCs are under pressure to scale. October 9, 2025 - 5 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email